New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
New studies reveal rare but real risk of GLP-1 drugs
July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes,…
An enzyme might help fight against your body’s aging
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism
Dual agonism of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors (GLP-1R and GIPR, respectively), in the…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
TGA issues warning over GLP-1-based drugs’ potential to cause rare eye disorder
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…
The Exercise Paradox: Why Workouts Don’t Guarantee Weight Loss
Exercise may do less for initial weight loss than commonly assumed, but it could be crucial for preventing…
America’s GLP-1 use nearly quadruples in just two years
America is slimming down — one shot at a time. The number of US adults turning to blockbuster…
Scientists show how sweeteners slow the growth of certain gut bacteria
Cambridge researchers have shown how commonly-used sweeteners slow the growth of certain gut bacteria. One sweetener in particular…
Cancer rates are expected to nearly double in the next 24 years
Cancer diagnoses worldwide are expected to climb to 35 million annually by 2050, up from 20.6 million in…
Experts weigh risks, benefits of OTC glucose monitors for children
You get a CGM, you get a CGM, everybody gets a CGM? For the first time in the…